Angela Norton Email

VP and Head Platform . Prologue Medicines

,

Location

LinkedIn

Current Roles

Employees:
33
Revenue:
$6.2M
About
Prologue is designing powerful new medicines by unlocking the viral proteome. The company’s state-of-the-art DELVE™ Platform systematically identifies and evaluates viral proteins and their unique features for their potential to precisely regulate human physiology. By co-opting viral evolution, Prologue is expanding the functional boundaries of proteins encoded by the human genome to create new programmable medicines. Prologue was founded by Flagship Pioneering in 2021.
Prologue Medicines Address

null, null
United States
Prologue Medicines Email